Position in ABSI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,932,688
+$14,472,813 QoQ
Shares Held
1,374,693
+182.5% QoQ
Ownership
0.801%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 27%
Shared 0%
None 73%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. ABSI ranks #115 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,932,688 | 1,374,693 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,459,875 | 486,625 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,161,142 | 1,478,838 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,948,396 | 969,868 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,210,642 | 1,249,278 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,659,162 | 1,457,835 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,210,822 | 462,147 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,916,513 | 501,706 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $410,179 | 133,176 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $751,909 | 132,379 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $202,733 | 48,270 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $62,717 | 47,515 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $144,625 | 95,149 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $205,009 | 117,149 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $227,381 | 108,278 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $280,359 | 89,572 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $176,227 | 53,081 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $207,462 | 24,610 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $141,826 | 17,296 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $33,901 | 2,915 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||